Wednesday, November 13, 2024
HomeIndustriesHealthcare

Healthcare

Green Valley Obtains IND Approval from U.S. FDA for Sodium Oligomannate’s Global Phase II Clinical Trial in Treating Parkinson’s Disease

On January 13, 2022, Green Valley (Shanghai) Pharmaceuticals Co., Ltd. received the letter from the US Food and Drug Administration (FDA) on the Investigational...

Kaiser Permanente Joins Graphite Health to Accelerate Digital Transformation of Health Care

Graphite Health, a member-led company intent on transforming digital health care to improve patient outcomes and lower costs, announced today that Kaiser Permanente is...

Mitsubishi Tanabe Pharma America Announces FDA Acceptance of New Drug Application (NDA) for Oral Edaravone Formulation for the Treatment of ALS

Mitsubishi Tanabe Pharma America, Inc. (MTPA) announced the U.S. Food and Drug Administration (FDA) has accepted the new drug application (NDA) for an investigational...

GenomOncology Pathology Workbench to Support OmniSeq’s Genomic Profiling Test for Solid Tumors

GenomOncology announced that GenomOncology (GO) Pathology Workbench has been selected by Labcorp's OmniSeq to support the analysis and reporting of OmniSeq INSIGHT℠, a comprehensive...

PureTech Founded Entity Gelesis, the Maker of Plenity for Weight Management, Will Debut as a Publicly Traded Company

PureTech Health plc, a clinical-stage biotherapeutics company noted that its Founded Entity, Gelesis, Inc. (“Gelesis”), the maker of Plenity®, an FDA-cleared weight management approach,...
0FansLike
0FollowersFollow
spot_img

Hot Topics